STRATEC Biomedical (SBS) Stock Statistics & Valuation Metrics

STRATEC Biomedical has a market cap or net worth of €274.12M. The enterprise value is €654.98M.

STRATEC Biomedical has 12.16M shares outstanding. The number of shares has decreased by -2.65% in one year.

STRATEC Biomedical’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of STRATEC Biomedical is ―. STRATEC Biomedical’s PEG ratio is ―.

In the last 12 months, STRATEC Biomedical had revenue of €250.54M and earned €10.01M in profits. Earnings per share was €0.84.

In the last 12 months, operating cash flow was €34.15M and capital expenditures -€15.78M, giving a free cash flow of €18.37M billion.

STRATEC Biomedical pays an annual dividend of €0.55, resulting in a dividend yield of 2.33%

STRATEC Biomedical upcoming earnings date is Apr 29, 2025, Before Open.

STRATEC Biomedical as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, STRATEC Biomedical has paid €3.56M in taxes.

STRATEC Biomedical EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

STRATEC Biomedical has €35.13M in cash and marketable securities with €152.54M in debt, giving a net cash position of €117.40M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for STRATEC Biomedical is €40.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy